Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions

Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targetin...

Full description

Saved in:
Bibliographic Details
Main Authors: Ferrara, Giovanni (Author) , Luppi, Fabrizio (Author) , Birring, Surinder S. (Author) , Cerri, Stefania (Author) , Caminati, Antonella (Author) , Sköld, Magnus (Author) , Kreuter, Michael (Author)
Format: Article (Journal)
Language:English
Published: February 7, 2018
In: European respiratory review
Year: 2018, Volume: 27, Issue: 147, Pages: 1-11
ISSN:1600-0617
DOI:10.1183/16000617.0076-2017
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1183/16000617.0076-2017
Verlag, lizenzpflichtig, Volltext: https://err.ersjournals.com/content/27/147/170076
Get full text
Author Notes:Giovanni Ferrara, Fabrizio Luppi, Surinder S. Birring, Stefania Cerri, Antonella Caminati, Magnus Sköld and Michael Kreuter
Description
Summary:Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.
Item Description:Gesehen am 18.05.2020
Physical Description:Online Resource
ISSN:1600-0617
DOI:10.1183/16000617.0076-2017